Canada markets open in 4 hours 56 minutes

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.15-0.69 (-1.57%)
At close: 04:00PM EDT
43.15 0.00 (0.00%)
After hours: 06:29PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
862,989
829,253
660,116
443,310
267,594
Cost of Revenue
185,520
192,361
139,304
81,413
43,367
Gross Profit
677,469
636,892
520,812
361,897
224,227
Operating Expenses
Research Development
77,495
76,363
66,607
35,672
34,236
Selling General and Administrative
146,959
149,182
143,526
50,323
45,736
Total Operating Expenses
298,155
299,318
253,281
85,995
79,972
Operating Income or Loss
379,314
337,574
267,531
275,902
144,255
Interest Expense
18,726
18,762
16,947
7,526
20,378
Total Other Income/Expenses Net
31,531
29,517
-1,666
-19,858
5,425
Income Before Tax
392,119
348,329
248,918
248,518
129,302
Income Tax Expense
73,317
66,735
46,789
-154,192
217
Income from Continuing Operations
318,802
281,594
202,129
402,710
129,085
Net Income
318,802
281,594
202,129
402,710
129,085
Net Income available to common shareholders
318,802
281,594
202,129
402,710
129,085
Basic EPS
1.91
2.13
1.48
2.86
0.95
Diluted EPS
1.87
2.10
1.44
2.74
0.91
Basic Average Shares
133,489
131,927
136,844
140,646
136,206
Diluted Average Shares
136,269
134,197
140,608
146,796
141,463